Safety and effectiveness of blind percutaneous liver biopsy: analysis of 1412 procedures
about
Chronic hepatitis C and liver fibrosis.Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis.Urinary metabolite profiling offers potential for differentiation of liver-kidney yin deficiency and dampness-heat internal smoldering syndromes in posthepatitis B cirrhosis patients.Accuracy of ultrasound and noninvasive markers of fibrosis to identify patients with cirrhosisAssessing inflammatory liver injury in an acute CCl4 model using dynamic 3D metabolic imaging of hyperpolarized [1-(13)C]pyruvateLIVER BIOPSY: IMPORTANCE OF SPECIMEN SIZE IN THE DIAGNOSIS AND STAGING OF CHRONIC VIRAL HEPATITIS.Improving hepatocellular carcinoma screening: applying lessons from colorectal cancer screening.Safety and performance of liver biopsies in liver transplant recipients.Clinical value and safety of liver biopsies in patients transplanted for hepatitis C virus-related end-stage liver disease.Role of percutaneous liver biopsy.DNA methylation patterns of peroxisome proliferator-activated receptor gamma gene associated with liver fibrosis and inflammation in chronic hepatitis B.Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease.How often do our liver core biopsies reach current definitions of adequacy?Adequacy of percutaneous non-targeted liver biopsy under real-time ultrasound guidance when comparing the Biopince™ and Achieve™ biopsy needle.Does a calculated "NAFLD fibrosis score" reliably negate the need for liver biopsy in patients undergoing bariatric surgery?A template for a clinico-pathological audit of medical liver biopsies.Liver dynamic contrast-enhanced MRI for staging liver fibrosis in a piglet model.
P2860
Q26825671-710A3347-F394-4819-80AF-C22013EFD074Q30412709-B56ADD53-4E9F-4339-B11E-5F7B70EE387CQ35034053-98BDB29D-17B7-450D-87F5-46975D664708Q35685126-329CFCE8-E244-44DB-8F34-9014BF82F996Q36483079-4EF205C2-8F68-4A75-9821-6212ADC28898Q36692315-F02CDE45-728E-495E-B064-3A18B8C7559AQ36724362-D0AF208B-E277-419B-AFFB-7A983F5CFA67Q40214428-BA3AEF17-5533-4D34-91DF-9D64AEEEEEBFQ41664208-6E449803-F4DE-4ACC-82AB-3B06A169DBF4Q42177964-01C8F370-4E11-4EC3-95E2-B2B302F79D31Q44987446-0FABE869-C7E1-4C23-B175-864067DBEC2BQ45066338-60DEADC9-A065-4670-80D4-3C2A6FE3922CQ46098473-E078C8BC-B745-41DF-84A0-7077ABD4ADE4Q47875192-8437B44E-BEC4-488E-B7F5-10B54518D7F3Q51215787-61F3EF0A-B1C8-4E29-8DBE-6560B2C86361Q52836497-423E0101-C1FC-4962-A9D6-129AB047BABBQ53091983-AEF4CC1E-A842-477C-9B54-49D0072A25C9
P2860
Safety and effectiveness of blind percutaneous liver biopsy: analysis of 1412 procedures
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Safety and effectiveness of blind percutaneous liver biopsy: analysis of 1412 procedures
@ast
Safety and effectiveness of blind percutaneous liver biopsy: analysis of 1412 procedures
@en
type
label
Safety and effectiveness of blind percutaneous liver biopsy: analysis of 1412 procedures
@ast
Safety and effectiveness of blind percutaneous liver biopsy: analysis of 1412 procedures
@en
prefLabel
Safety and effectiveness of blind percutaneous liver biopsy: analysis of 1412 procedures
@ast
Safety and effectiveness of blind percutaneous liver biopsy: analysis of 1412 procedures
@en
P2093
P2860
P1433
P1476
Safety and effectiveness of blind percutaneous liver biopsy: analysis of 1412 procedures
@en
P2093
Aleksandra Szymczak
Andrzej Gladysz
Malgorzata Inglot
P2860
P356
10.5812/KOWSAR.1735143X.4388
P407
P577
2012-01-20T00:00:00Z